Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3854)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2022 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wajsbrot NB, Leite NC, Salles GF, Villela-Nogueira CA. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring. World J Gastroenterol 2022; 28(25): 2890-2899 [PMID: 35978876 DOI: 10.3748/wjg.v28.i25.2890] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v28/i25/2890.htm |
| Number | Citing Articles |
| 1 |
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
|
| 2 |
Liyun Wang, Kahua Liu, Liang Deng, Guanyu Zhou, Wei Qian, Keshu Xu. Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease. Applied Biochemistry and Biotechnology 2023; doi: 10.1007/s12010-023-04694-5
|
| 3 |
Hui‐Chin Chang, Shuo‐Yan Gau. Letter: hereditary role in non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2023; 57(2): 274 doi: 10.1111/apt.17317
|
| 4 |
Yu Sun, Yongming Shen, Xiurui Liang, Huilin Zheng, Yitong Zhang. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review. Clinical Therapeutics 2023; 45(3): 234 doi: 10.1016/j.clinthera.2023.02.001
|
| 5 |
Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Paulo Henrique Condeixa Franca, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Cristiane A. Villela-Nogueira. Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2024; 69(2): 634 doi: 10.1007/s10620-023-08214-7
|
| 6 |
Ruowen Li, Mingjian Zhao, Chengxu Miao, Xiaojia Shi, Jinghui Lu. Identification and validation of key biomarkers associated with macrophages in nonalcoholic fatty liver disease based on hdWGCNA and machine learning. Aging 2023; 15(24): 15451 doi: 10.18632/aging.205374
|
| 7 |
Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv. Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336493
|